LANTHEUS HOLDINGS INC (LNTH) Stock Price, Forecast & Analysis
NASDAQ:LNTH • US5165441032
LNTH Key Statistics, Chart & Performance
The current stock price of LNTH is 73.435 USD. In the past month the price increased by 9.96%. In the past year, price decreased by -5.57%.
LNTH Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to LNTH. When comparing the yearly performance of all stocks, LNTH turns out to be only a medium performer in the overall market: it outperformed 67.69% of all stocks.
LNTH Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to LNTH. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
LNTH Financial Highlights
Over the last trailing twelve months LNTH reported a non-GAAP Earnings per Share(EPS) of 5.96. The EPS decreased by -14.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.99% | ||
| ROA | 7.37% | ||
| ROE | 14.98% | ||
| Debt/Equity | 0.51 |
LNTH Forecast & Estimates
19 analysts have analysed LNTH and the average price target is 85.13 USD. This implies a price increase of 15.93% is expected in the next year compared to the current price of 73.435.
For the next year, analysts expect an EPS growth of -16.21% and a revenue growth -1.1% for LNTH
LNTH Ownership
LNTH Latest News, Press Relases and Analysis
LNTH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 33.17 | 65.423B | ||
| COO | COOPER COS INC/THE | 18.22 | 16.476B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.87 | 13.634B | ||
| SOLV | SOLVENTUM CORP | 11.16 | 12.651B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 19.74 | 4.874B | ||
| ICUI | ICU MEDICAL INC | 18.75 | 3.877B | ||
| HAE | HAEMONETICS CORP/MASS | 11.17 | 2.844B | ||
| XRAY | DENTSPLY SIRONA INC | 7.94 | 2.502B | ||
| NEOG | NEOGEN CORP | 32.68 | 2.465B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LNTH
Company Profile
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.
Company Info
LANTHEUS HOLDINGS INC
331 Treble Cove Road
North Billerica MASSACHUSETTS 01862 US
CEO: Mary Anne Heino
Employees: 808
Phone: 19786718001
LANTHEUS HOLDINGS INC / LNTH FAQ
What does LNTH do?
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.
What is the stock price of LANTHEUS HOLDINGS INC today?
The current stock price of LNTH is 73.435 USD. The price decreased by -0.59% in the last trading session.
Does LANTHEUS HOLDINGS INC pay dividends?
LNTH does not pay a dividend.
What is the ChartMill technical and fundamental rating of LNTH stock?
LNTH has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Which stock exchange lists LNTH stock?
LNTH stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of LANTHEUS HOLDINGS INC (LNTH)?
The PE ratio for LANTHEUS HOLDINGS INC (LNTH) is 12.32. This is based on the reported non-GAAP earnings per share of 5.96 and the current share price of 73.435 USD.
What is the next earnings date for LNTH stock?
LANTHEUS HOLDINGS INC (LNTH) will report earnings on 2026-02-26, before the market open.